910805-03-7

Basic information

• Product Name: N-[1-(3-formylphenyl)piperidin-3-ylmethyl]-2-(4-chlorophenyl)-4-methylthiazole-5-carboxamide
• Synonyms: N-[1-(3-formylphenyl)piperidin-3-ylmethyl]-2-(4-chlorophenyl)-4-methylthiazole-5-carboxamide
• CAS NO: 910805-03-7
• Molecular Weight: 453.992
• Mol File: 910805-03-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[1-(3-formylphenyl)piperidin-3-ylmethyl]-2-(4-chlorophenyl)-4-methylthiazole-5-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[1-(3-formylphenyl)piperidin-3-ylmethyl]-2-(4-chlorophenyl)-4-methylthiazole-5-carboxamide(910805-03-7)
• EPA Substance Registry System: N-[1-(3-formylphenyl)piperidin-3-ylmethyl]-2-(4-chlorophenyl)-4-methylthiazole-5-carboxamide(910805-03-7)

Safety Data

• Hazardous Substances Data: 910805-03-7(Hazardous Substances Data)

Upstream product

• 54001-17-1 2-(4-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxylic acid 
• 162167-97-7 tert-butyl 3-(aminomethyl)piperidine-1-carboxylate 
• 876147-54-5 N-(piperidin-3-ylmethyl)-2-(4-chlorophenyl)-4-methylthiazole-5-carboxamide 
• 87199-16-4 3-Formylphenylboronic acid 

Relevant articles and documents

NOVEL CYCLIC AMINOPHENYLALKANOIC ACID DERIVATIVE

The present invention provides cyclic aminophenylalkanoic acid derivatives that act as agonists for human peroxisome proliferator-activated receptors (PPARs), in particular human PPARα isoform, and are effective in the treatment of abnormal lipid metabolism, diabetes and other disorders. The present invention also provides addition salts of such cyclic aminophenylalkanoic acid derivatives and pharmaceutical compositions containing these compounds. Specifically, the present invention provides cyclic aminophenylalkanoic acid derivatives represented by the following general formula (1) : or pharmaceutically acceptable salts thereof.